Personalized predictions study for a 25 year old woman who takes Mobic, Plaquenil - from FDA reports


We analyzed 834,686 related reports to generate the predictions. There are 2 types of predictions: symptoms and conditions with supporting statistic provided. You can discuss the predictions with your healthcare provider.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

834,686 related reports were analyzed:

Most common symptoms:

Nausea
  • 6.23% for females aged 25 (±5) who take mobic
  • 6.23% for females aged 25 (±5) who take plaquenil

Most common co-existing conditions:

Birth control
  • 17.12% for females aged 25 (±5) who take mobic
  • 17.12% for females aged 25 (±5) who take plaquenil
Multiple sclerosis
  • 5.24% for females aged 25 (±5) who take mobic
  • 5.24% for females aged 25 (±5) who take plaquenil

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.